Shanghai Hutchison Pharmaceutical was awarded "National Technology Innovation Demonstration Enterprise"

Shanghai, November 24, 2021 /PRNewswire/ - On November 19, the Ministry of Industry and Information Technology announced the list of 2021 "National Technological Innovation Demonstration Enterprises", a total of 58 companies, only 2 in Shanghai, and Shanghai Hutchison Pharmaceuticals Listed among them

Notice of the Ministry of Industry and Information Technology on publishing the list of national technological innovation demonstration enterprises in 2021: https:// award of "National Technological Innovation Demonstration Enterprise" this time shows that Shanghai Hutchison Pharmaceuticals has scale and technological advantages compared with international or domestic companies in the same industry, and has a leading role in the field of technological innovation in the industry.

Being awarded the "National Technological Innovation Demonstration Enterprise" is also the result of the company's long-term adherence to the "Technology Leading Development" strategy

DNT is to promote the modernization of traditional Chinese medicine in basic research on the internationalization of Chinese medicine to achieve the lifting of "Chinese Pharmacopoeia" standards to international standards, it is in exploring the feasible path drug internationalization

In 2020, the company was approved for 2 clinical trial licenses for class 1.

In addition, the company has overcome 16 key technologies in the whole process of toad breeding, and is the first in the country to establish a database for the quality evaluation of toad venom samples

The "National Technological Innovation Demonstration Enterprise" declares qualifications as a unit with a "National Enterprise Technology Center".

The "National Demonstration Enterprise for Technological Innovation" implements dynamic management, with a review and evaluation every three years